C126H146N20O12 — CID 158618701
N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide (PubChem CID 158618701) has the molecular formula C126H146N20O12 and a molecular weight of 2132.68 g/mol. Its IUPAC name is N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide.
| Compound Name | N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide |
|---|---|
| PubChem CID | 158618701 |
| Molecular Formula | C126H146N20O12 |
| Molecular Weight | 2132.68 g/mol |
| Exact Mass | 2131.14 |
| IUPAC Name | N-(1-amino-3-hydroxy-1-oxopropan-2-yl)-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-isoquinolin-3-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-5-[1-(4-tert-butylphenyl)-3-pyridin-2-ylpyrazol-5-yl]pentanamide;N-[(2R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-6-[1-(4-propan-2-ylphenyl)-3-pyridin-2-ylpyrazol-5-yl]hexanamide |
| SMILES | CC(C)(C)c1ccc(-n2nc(-c3cc4ccccc4cn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)NC(CO)C(N)=O)cc1.CC(C)c1ccc(-n2nc(-c3ccccn3)cc2CCCCCC(=O)N[C@H](Cc2ccc(O)cc2)C(N)=O)cc1 |
| InChI | InChI=1S/C36H39N5O3.2C32H37N5O3.C26H33N5O3/c1-36(2,3)27-14-16-28(17-15-27)41-29(22-32(40-41)31-21-25-8-4-5-9-26(25)23-38-31)10-6-7-11-34(43)39-33(35(37)44)20-24-12-18-30(42)19-13-24;1-32(2,3)23-13-15-24(16-14-23)37-25(21-28(36-37)27-9-6-7-19-34-27)8-4-5-10-30(39)35-29(31(33)40)20-22-11-17-26(38)18-12-22;1-22(2)24-13-15-25(16-14-24)37-26(21-29(36-37)28-9-6-7-19-34-28)8-4-3-5-10-31(39)35-30(32(33)40)20-23-11-17-27(38)18-12-23;1-18(2)19-11-13-20(14-12-19)31-21(16-23(30-31)22-9-6-7-15-28-22)8-4-3-5-10-25(33)29-24(17-32)26(27)34/h4-5,8-9,12-19,21-23,33,42H,6-7,10-11,20H2,1-3H3,(H2,37,44)(H,39,43);6-7,9,11-19,21,29,38H,4-5,8,10,20H2,1-3H3,(H2,33,40)(H,35,39);6-7,9,11-19,21-22,30,38H,3-5,8,10,20H2,1-2H3,(H2,33,40)(H,35,39);6-7,9,11-16,18,24,32H,3-5,8,10,17H2,1-2H3,(H2,27,34)(H,29,33)/t33-;29-;30-;/m111./s1 |
| InChIKey | HXSJBYJGINNTQV-OXMZAITISA-N |
| XLogP | 19.08 |
| TPSA | 492.52 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 47 |
| Heavy Atoms | 158 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2132.68 |
| LogP ≤ 5 | 19.08 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 24 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|